Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-29 @ 8:03 AM
Study NCT ID:
NCT00941928
Status:
TERMINATED
Last Update Posted:
2014-05-22
First Post:
2009-07-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-16
First Submit QC Date:
None
Study First Post Date:
2009-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-22
Results First Submit QC Date:
None
Results First Post Date:
2013-08-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-19
Last Update Post Date:
2014-05-22
Last Update Post Date Type:
ESTIMATED